YOLFTbeta
Wattanapat Hospital Trang Public Company Limited

Wattanapat Hospital Trang Public Company Limited

WPH · BK · Healthcare / Medical Care Facilities

6.00THB-0.05 (-0.83%)

Price History

Full chart

Market Stats

Previous Close6.05
Open6.05
Day Range6.00 – 6.05
52-Week Range5.14 – 7.81
Volume141.11K
Market Cap4.32B
P/E (TTM)12.60
Forward P/E10.00
EPS0.48
Dividend Yield1.22%
Beta0.53
50-Day Avg6.09
200-Day Avg6.00

About

Wattanapat Hospital Trang Public Company Limited, together with its subsidiaries, provides medical services in Thailand. It operates orthopedic, neurosurgery, neurology, surgery, cardiology, internal medicine, obstetrics and gynecology, gastrointestinal and liver, pediatric, ophthalmology, ear nose and throat, dental, and skin and beauty, hyperbaric oxygen therapy, kidney clinic and hemodialysis, diabetes thyroid and endocrinology, physical therapy, and orthopedic clinics, as well as wellness, hyperbaric oxygen therapy, X-Ray and MRI, emergency, WPH emergency centers. The company was founded in 1957 and is headquartered in Trang, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Somchai Chansawang M.D.
  • Employees0
  • Headquarters247/2, Phatalung Road, Trang, Thailand, 92000, Thailand
  • Websitehttps://wattanapat.co.th

Leadership

  • Dr. Somchai Chansawang M.D.CEO & Executive Director · b. 1956
  • Ms. Amara LeelawatExecutive Vice Chairman · b. 1933
  • Mr. Chane LaosonthornExecutive VP & Executive Director · b. 1987
  • Mr. Pornlert Boonsontisuk D.D.S.Executive Director · b. 1961
  • Mr. Pinit Laosunthorn D.D.S.Executive Director · b. 1956
  • Mr. Wirawit WannarukAccounting & Finance Manager and Accounting Supervisor · b. 1981
  • Ms. Mantanee RattamaneeHead of Investor Relations
  • Ms. Tipparat KhaimarnHead of the Compliance Unit & Company Secretary
  • Ms. Supanun AramayHospital Director · b. 1986
  • Mr. Paisan PuratjaroenchaiHead of Internal Audit

Financials

Income Statement

Currency: THB2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue430.86M476.54M542.00M533.31M625.87M754.47M705.47M1.23B1.15B1.46B2.03B2.33B
Growth (%)-+10.60%+13.74%-1.60%+17.36%+20.55%-6.49%+73.83%-6.59%+27.42%+39.23%+14.65%
Cost of Revenue300.73M315.21M354.53M382.27M430.52M614.22M602.21M793.99M821.26M1.09B1.39B1.56B
Gross Profit130.13M161.33M187.47M151.05M195.36M140.24M103.26M432.30M324.24M366.10M638.51M769.59M
Gross Margin30.20%33.85%34.59%28.32%31.21%18.59%14.64%35.25%28.31%25.08%31.42%33.03%
Operating Expense141.45M112.46M106.22M127.16M141.11M146.41M129.77M135.91M166.09M212.21M255.93M325.31M
Operating Income-11.32M48.87M81.25M23.89M54.25M-6.16M-26.51M296.39M158.15M153.88M382.58M444.28M
Operating Margin-2.63%10.26%14.99%4.48%8.67%-0.82%-3.76%24.17%13.81%10.54%18.83%19.07%
EBITDA72.00M86.81M116.71M60.81M82.26M41.19M33.90M370.41M238.67M273.39M532.73M610.44M
EBITDA Margin16.71%18.22%21.53%11.40%13.14%5.46%4.81%30.21%20.84%18.73%26.22%26.20%
Net Income-16.61M43.47M72.24M24.19M51.48M-6.48M-33.69M232.29M115.66M92.91M278.85M351.76M
Net Income Margin-3.86%9.12%13.33%4.54%8.22%-0.86%-4.78%18.94%10.10%6.37%13.72%15.10%
Interest Expense10.04M6.69M7.56M5.15M1.92M6.88M9.54M13.92M15.04M42.22M45.33M37.89M
Interest Expense % of Total Revenue2.33%1.40%1.39%0.97%0.31%0.91%1.35%1.14%1.31%2.89%2.23%1.63%

Balance Sheet

Currency: THB2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets486.07M496.57M631.26M926.07M1.19B1.32B1.46B1.89B2.21B2.57B2.78B3.58B
Total Liabilities231.19M224.99M280.29M79.84M299.82M473.12M690.76M906.41M1.17B1.47B1.17B1.54B
Total Equity254.88M271.58M343.74M831.84M872.63M836.30M771.30M980.91M1.04B1.06B1.58B1.93B
Cash18.54M28.13M36.98M25.75M49.18M11.49M25.97M39.35M39.33M76.98M66.20M130.51M
Total Debt147.93M121.14M188.54M697.70K182.13M359.77M587.21M704.55M897.37M1.22B929.77M1.23B
Net Debt129.39M93.01M151.56M-25.05M132.95M348.28M561.24M665.20M858.04M1.14B863.57M1.10B

Cash Flow

Currency: THB2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow79.34M51.07M111.67M48.34M77.84M34.63M31.54M60.56M408.42M235.48M476.44M497.73M
Investing Cash Flow-730.00K-1.72M-154.13M-332.55M-225.02M-200.66M-182.99M-120.18M-526.20M-446.12M-362.27M-729.95M
Financing Cash Flow-79.18M-39.75M51.30M272.98M170.60M128.34M165.93M73.00M117.76M230.63M-124.94M296.52M
Capital Expenditure21.12M20.72M171.06M104.22M458.16M205.85M187.27M120.44M528.73M502.54M289.83M860.51M
Free Cash Flow58.22M30.35M-59.39M-55.88M-380.32M-171.22M-155.73M-59.88M-120.30M-225.25M186.61M-362.78M
Dividends Paid10.80M10.80M16.00M232.60M10.80M37.50M34.74M22.56M60.00M66.00M66.00M1.50M
FCF to OCF73.38%59.43%-53.18%-115.58%-488.60%-494.41%-493.76%-98.87%-29.46%-95.66%39.17%-72.89%
Dividend Paid to FCF18.55%35.58%-26.94%-416.27%-2.84%-21.90%-22.31%-37.67%-49.87%-29.30%35.37%-0.41%

Earnings

Report DateDec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Feb 21, 2025May 14, 2025Aug 14, 2025Nov 17, 2025Feb 26, 2026May 15, 2026Aug 17, 2026
EPS Estimate-----------------------------------
EPS Actual0.010.040.010.020.01-0.01-0.010.020.000.00-0.04-0.00-0.01-0.02-0.030.110.290.090.030.07-0.010.03-0.000.050.070.160.050.100.090.260.050.050.140.270.03
Surprise-----------------------------------
Timing-----------------------------------

Key Statistics & Ratios

Market Cap4.32B
Enterprise Value5.65B
Trailing P/E12.60
Forward P/E10.00
Price / Sales1.78
Price / Book2.13
EPS0.48
Book Value2.91
Revenue (TTM)2.43B
Gross Profit (TTM)793.92M
EBITDA599.30M
Profit Margin14.10%
Operating Margin5.11%
Return on Equity16.86%
Return on Assets7.58%
Shares Outstanding714.13M
Shares Float258.51M
Beta0.53
Dividend Yield1.22%
Dividend Rate0.07
Payout Ratio15.04%

Dividends

20261×
0.07Mar 11, 2026
20251×
0.00Mar 7, 2025
20241×
0.09Mar 11, 2024
20231×
0.10Mar 10, 2023
20221×
0.09Mar 10, 2022
20211×
0.03Mar 10, 2021
20201×
0.05Apr 28, 2020
20191×
0.04May 3, 2019
20181×
0.02May 4, 2018

Stock Splits

  • Mar 11, 202651:50
  • Mar 7, 202526:25
  • Mar 11, 202451:50